Sentences with phrase «chair of the oncology»

In 1996, I relinquished an endowed chair of oncology at UNC Chapel Hill to become the scientific director of the Division of Clinical Sciences at the National Cancer Institute (NCI) near Washington, D.C..

Dr. Vickery served on the Executive Committee for Veterinary Cancer Society and served as Chair of the Oncology Forum Planning Committee for the American College of Veterinary Internal Medicine (2011 - 2014).

Dr. Vickery holds the position of Chair of the Oncology Forum Planning Committee for the American College of Veterinary Internal Medicine.

Past professional roles include President of the Veterinary Cooperative Oncology Group, member - at - large for the Veterinary Cancer Society, and Chair of the Oncology Certifying Examination Committee.

Not exact matches

That's how Charles Sawyers, a 2009 Lasker Award winner and chair of human oncology and pathogenesis at Memorial Sloan - Kettering Cancer Center in New York City, made the connection with Bristol Myers Squibb (BMS) that led to second - generation treatments for chronic myeloid leukemia (CML).

According to Vernon K. Sondak, M.D., chair of the Department of Cutaneous Oncology at Moffitt Cancer Center, «it is time to embrace the opportunity to decrease melanoma mortality through risk - stratified education and screening.»

The finding has already garnered attention from researchers across Canada, including internationally recognized brain tumor scientist and neurosurgeon Dr. James Rutka, Professor and Chair, Department of Surgery, University of Toronto and Dr. Rolando Del Maestro, William Feindel Professor Emeritus in Neuro - Oncology, McGill University.

Other UT Southwestern faculty members who contributed to this research are: Dr. Boning Gao, Assistant Professor with the Hamon Center for Therapeutic Oncology Research and Pharmacology; Dr. Kimmo Hatanpaa, Associate Professor of Pathology; Dr. Kemp Kernstine, Professor of Cardiovascular and Thoracic Surgery and holder of the Robert Tucker Hayes Foundation Distinguished Chair in Cardiothoracic Surgery; Dr. Yang Xie, Associate Professor of Clinical Sciences and Bioinformatics; Dr. Hong Zhu, Assistant Professor of Clinical Sciences and with the Simmons Cancer Center; Dr. Farjana Fattah, Assistant Professor with the Simmons Cancer Center and Pathology; Dr. Masaya Takahashi, Associate Professor with the Advanced Imaging Research and Radiology; Dr. Bipasha Mukherjee, Assistant Professor of Radiation Oncology; Dr. Sandeep Burma, Associate Professor of Radiation Oncology; and Dr. Jonathan Dowell, Professor of Internal Medicine;

Monica Bertagnolli, chief of the Division of Surgical Oncology at Brigham and Women's Hospital and chair of the Alliance for Clinical Trials in Oncology, a nationwide effort to test new therapies, says she was thrilled that the president used the word «cure» in his speech at all.

«While the presence of lymphocytes in tumors is often associated with better clinical outcomes, this research adds clarity on the diversity of T cells within the tumor environment and their influence on ovarian cancer outcomes,» says first author Kunle Odunsi, MD, PhD, FRCOG, FACOG, Deputy Director, M. Steven Piver Professor and Chair of Gynecologic Oncology, and Executive Director of the Center for Immunotherapy at Roswell Park.

Alexander Anderson, Ph.D., chair of the Department of Integrated Mathematical Oncology (IMO) and Mark Robertson - Tessi, an applied research scientist in IMO, recently published a commentary on an integrative approach used to study cancer heterogeneity.

«Despite the intense therapeutic and surgical regimen typically used to treat ovarian cancer, outcomes remain poor,» said William Small Jr., MD, chair, Department of Radiation Oncology, LUHS.

Principal investigator E. Shelley Hwang, M.D., chief of breast surgery at the Duke Cancer Institute and vice chair of research in the Duke University Department of Surgery, will lead the study through the cooperative group, The Alliance for Clinical Trials in Oncology.

One has to receive a copy of the abnormal gene from both parents to have the disease,» said Dr. Buchanan, who holds the Children's Cancer Fund Distinguished Chair in Pediatric Oncology & Hematology.

Second, we believe the vaccine may be particularly beneficial for a group of patients with the HLA - A2 type, which suggests that as we move forward, there may be advantages in targeting this population,» said John Yu, MD, vice chair of the Department of Neurosurgery, director of surgical neuro - oncology, medical director of the Brain Tumor Center and neurosurgical director of the Gamma Knife Program at Cedars - Sinai.

«Given that pemetrexed combined with cisplatin may be less toxic than and as active as cisplatin plus paclitaxel and that it can be combined with bevacizumab, investigating the comparison of cisplatin - pemetrexed plus bevacizumab with cisplatin - paclitaxel plus bevacizumab would be the next appropriate step,» said Dr. Miller, who holds the Amy and Vernon E. Faulconer Distinguished Chair in Medical Science and the Dallas Foundation Chair in Gynecologic Oncology.

Rangnekar, a professor in the department of radiation medicine, also holds the Alfred Cohen Endowed Chair in Oncology Research.

«To support this goal and accelerate these efforts, changes in directions of research support and funding may be required,» co-authors Padmanee Sharma, M.D., Ph.D., professor of Genitourinary Medical Oncology and Immunology, and Jim Allison, Ph.D., chair of Immunology, said in the review.

«Despite the concerns, the development of BRAF inhibitors is a major milestone in treating patients with BRAF - mutant melanoma,» concluded study co-author Vernon K. Sondak, M.D., chair of the Cutaneous Oncology Program at Moffitt.

«AML is a disease in which fewer than 30 percent of patients are cured,» said co-senior author Ulrich Steidl, M.D., Ph.D., associate professor of cell biology and of medicine and the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research at Einstein and associate chair for translational research in oncology at Montefiore.

«Our findings have potential implications for autism and seizure disorders that currently aren't treatable — at least not by targeting GABA,» said Eisenstat, the senior author of the study and chair of the Department of Oncology at the U of A as well as professor in the departments of Pediatrics and Medical Genetics.

Professor Patrizio Lancellotti, chair of the ESC EACVI / HFA Cardiac Oncology Toxicity Registry, said: «Patients with some forms of breast cancer are at greater risk of dying from heart disease than from cancer.

«This is something that's been on our minds for years, really since the early 2000s, and it's exciting to see it finally come to fruition,» said James Metz, MD, chair of Radiation Oncology at Penn Medicine.

But this is a different disease and the treatments that work in sun - caused melanoma don't work in non-sun melanoma,» says William A. Robinson, MD, investigator at the CU Cancer Center and the Rella and Monroe Rifkin Endowed Chair of Medical Oncology at the CU School of Medicine.

Other UT Southwestern researchers involved in the study were Dr. Ramzi Abdulrahman, Associate Professor of Radiation Oncology; Dr. Arthur Sagalowsky, Professor of Urology and Surgery, co-leader of the Kidney Cancer Program, who holds The Dr. Paul Peters Chair in Urology in Memory of Rumsey and Louis Strickland; Dr. Ivan Pedrosa, Associate Professor of Radiology and the Advanced Imaging Research Center, co-leader of the Kidney Cancer Program, who holds the Jack Reynolds, M.D., Chair in Radiology; Dr. Hak Choy, Chair and Professor of Radiation Oncology who holds The Nancy B. & Jake L. Hamon Distinguished Chair in Therapeutic Oncology Research; and Dr. James Brugarolas, Associate Professor of Internal Medicine and Developmental Biology, leader of the Kidney Cancer Program, and Virginia Murchison Linthicum Endowed Scholar; and other researchers including Stephen Chun, Dr. Nathan Cannon, and Dr. Nathan Kim.

Prof Nathan Cherny, former chair of the ESMO Palliative Care Working Group and initiator of the Designated Centres programme, said: «The ESMO Designated Centres programme is the premier initiative worldwide for providing incentives and a structured model to enable centres to develop integrated programmes in oncology and palliative care.

«With our approach, investigators simply combine an mTOR inhibitor and CD4 antibody to create an immunotherapy treatment, requiring no surgery and a drug with virtually no shelf life,» said Robert Figlin, MD, deputy director of the Samuel Oschin Comprehensive Cancer Institute and the Steven Spielberg Family Chair in Hematology - Oncology.

«While we need to better understand how these abnormally regulated metabolites activate oncogenic proteins, our intriguing discovery suggests novel therapeutic targets for this disease,» says principal investigator and study leader Arnab Chakravarti, MD, chair and professor of Radiation Oncology and co-director of the Brain Tumor Program at the OSUCCC — James.

«Historically, when treating early lung cancer with radiotherapy, progression at the site of the primary tumor was the most common failure resulting in suffering and death,» said lead study author Robert Timmerman, MD, professor and vice chair of the department of radiation oncology at the University of Texas Southwestern Medical Center in Dallas.

Michael Carducci, MD, AEGON Professor of Prostate Cancer Research and professor of oncology at Johns Hopkins Kimmel Cancer Center, who is also chair of the Prostate Cancer Subcommittee within the Genitourinary Oncology Committee of ECOG - ACRINoncology at Johns Hopkins Kimmel Cancer Center, who is also chair of the Prostate Cancer Subcommittee within the Genitourinary Oncology Committee of ECOG - ACRINOncology Committee of ECOG - ACRIN agrees.

«The powerful tissue resource used in this study was made possible by generous financial donations from Teresa's Foundation for Pancreatic Cancer and the Tim and Mary Ann McKenzie Chair of Surgical Oncology Professorship,» says Drifka.

He served as Chair of the Bioethics Committee of the Children's Oncology Group from 2002 - 2008, and was an appointed member of the Committee on Bioethics of the American Academy of Pediatrics from 1999 - 2005.

The Ludwig Center at the University of Chicago --- under the direction of Ralph Weichselbaum, MD, the Daniel K. Ludwig Professor and Chair of the Department of Radiation and Cellular Oncology, and Geoffrey Greene, PhD, the Daniel K. Ludwig Professor in the Ben May Cancer Research Institute at the University of Chicago — will focus on metastasis, the process by which cancer cells migrate from a primary tumor to multiple distant sites.

Dr. Kunle Odunsi is the deputy director of the Roswell Park Cancer Institute, where he also serves as the chair of the Department of Gynecologic Oncology, the executive director of the Center for Immunotherapy, and the co-Leader of the Tumor Immunology and Immunotherapy research program.

Dr. Stuart H. Orkin, the David G. Nathan Professor of Pediatrics, Harvard Medical School and chair, Department of Pediatric Oncology at Dana Farber Cancer Institute, will kick off the meeting as the honorary Mary Sue & Kenneth Coleman Life Sciences Lecturer.

As part of our coverage of the 2017 American Society of Clinical Oncology (ASCO) Annual Meeting, held June 2 — 6 in Chicago, we are speaking with Gordon Mills, MD, PhD, chair of the department of systems biology and professor of medicine and immunology at the University of Texas MD Anderson Cancer Center in Houston, about ways to incorporate homologous recombination markers into clinical practice for ovarian cancer.

Sagar Lonial, MD, FACP Professor, Emory School of Medicine Chair, Department of Hematology & Medical Oncology Chief Medical Officer Winship Cancer Institute of Emory University Atlanta, GA

Dr. Anand P. Jillella returns to the Medical College of Georgia at Augusta University July 1 as the J. Harold Harrison, MD, Distinguished University Chair in Medical Oncology.

Dr. Richard Booton is Lead Lung Cancer Clinician & Chair, Thoracic Oncology Board, GM Clinical Lead for Lung Cancer Screening at Manchester Thoracic Oncology Centre and North West Lung Centre & University Hospital of South Manchester, Member of the BTOG Steering Committee, Chair of the IASLC Communications Committee and IASLC Regent for UK and Ireland.

«In theory, it could lower the dose for cure for many cancers, which is great progress because any amount we can reduce the radiation means fewer complications,» said study co-author Ralph Weichselbaum, the Daniel K. Ludwig Distinguished Service Professor and chair of the Department of Radiation and Cellular Oncology, «and we also hope that the potential activation of the immune system may help us treat tumors that we just can't reach today.»

Shridar Ganesan, MD, PhD Omar Boraie Chair in Genomic Science Associate Director for Translational Science Director of Functional Genomics Shared Resource Co-Leader, Clinical Investigations and Precision Therapeutics Program Chief, Molecular Oncology Rutgers Cancer Institute of New Jersey Associate Professor of Medicine and Pharmacology Rutgers Robert Wood Johnson Medical School

In 2006, Greene was appointed co-director — along with Ralph Weichselbaum, MD, chair of the Department of Radiation Oncology — of the Ludwig Center for Metastasis Research, one of only six such centers in the country.

Kandel has held membership in numerous professional societies including: the American Surgical Association, American Board of Surgery (Pediatric Board), American College of Surgeons (fellow), American Pediatric Surgical Association (fellow), American Academy of Pediatrics (past chair of the publications committee, Section on Surgery), International Society of Paediatric Surgical Oncology, Society of Surgical Oncology, Society of University Surgeons, National Wilms Tumor Study and the New York Academy of Sciences.

He is an Associate Professor in the Department of Oncology and chairs the Alberta Prostate Cancer Research Initiative.

Presently, she is vice chair of the COG Neuroblastoma Disease Committee, as well as a member of the organization's Hematology / Oncology Discipline Steering Committee, Scientific Council and Executive Committee.

He also is Georgia Research Alliance Eminent Scholar and Chair in Cancer Research there, Lawrence W. Davis Professor and chairman of the Department of Radiation Oncology for the Emory University School of Medicine and associate vice president for cancer for Emory's Woodruff Health Sciences Center.

2017: Akila Viswanathan, M.D., M.P.H., executive vice chair, professor, and director of radiation oncology services for the National Capital Region campus and director of gynecological radiation oncology services for Johns Hopkins brought a pioneering new therapy to the Kimmel Cancer Center.

«When we think about radiation therapy, it is high technology, but the complexity of cancer requires that we have a better understanding of the biology,» says Marikki Laiho, the Willard and Lillian Hackerman Professor of Radiation Oncology and Vice Chair of Research for the Department of Radiation Oncology and Molecular Radiation Sciences.

Staff of this Program: Bruce Haffty, MD, Chair and Radiation Oncologist Laura Bond, MD, Radiation Oncologist Joel K. Braver, MD, Radiation Oncologist Alan Cohler, MD, Radiation Oncologist Ronald D. Ennis, MD, Radiation Oncologist and Medical Director, Clinical Network for Radiation Oncology Lara Hathout, MD, FRCPC, Radiation Oncologist Salma Jabbour, MD, Radiation Oncologist Sung Kim, MD, Radiation Oncologist Omar M. Mahmoud, MD, MSc, PhD, Radiation Oncologist Nisha Ohri, MD, Radiation Oncologist Rahul R. Parikh, MD, Radiation Oncologist Joseph P. Weiner, MD, Radiation Oncologist Jeff Ning Yue, PhD Vice-Chair and Chief, Radiation Physics Zhiyuan Shen, MD, PhD Research Scientist and Chief, Radiation Cancer Biology Bing Xia, PhD Research Scientist Dorothy Pierce, RN, RCN, MSN, APN - C, OCN, Advanced Practice Nurse Susan Schwartz, MSN, RN, APN, Advanced Practice Nurse Jacqueline Tull, RN, Registered Nurse Theresa Singley, RN, Registered Nurse Rihan Millevoi, Dosimetrist William Witherup, Chief Therapist Shushma Patel, Assistant Chief Therapist Ann Marie Maisel, Radiation Therapist Susan Resavy, Radiation Therapist Mary Kazio, Radiation Therapist Krystin Greene, Radiation Therapist Melissa Mareth, Radiation Therapist Lillian Hosein, Radiation Therapist Carie Straus, Radiation Therapist Kevin Sinn, Radiation Therapist Jenise Bell, Technical Assistant Autumn Banta, MSW, LSW, Social Worker

He is also Professor and Chair of the Department of Gynecologic Oncology, the M. Steven Piver Endowed Professor of Gynecologic Oncology at RPCI, and the Executive Director of the Center for Immunotherapy at RPCI.